Table 1 Sociodemographic, clinical, hormonal and therapeutic characteristics (n = 84)
Characteristics | n (%) |
|---|---|
Race | |
 White | 44 (52.4) |
 Black | 9 (10.7) |
 Hispanic | 31 (36.9) |
Income, R$a | |
 440–880 | 14 (16.7) |
 881–1.760 | 31 (36.9) |
  > 1.761 | 39 (46.5) |
Education | |
 Elementary School - Incomplete | 36 (42.9) |
 Elementary School - Complete | 9 (10.7) |
 High School - Incomplete | 6 (7.1) |
 High School - Complete | 21 (25.0) |
 Graduate degree | 12 (14.3) |
Menopausal status | |
 Premenopausal | 7 (8.3) |
 Postmenopausal | 77 (91.7) |
Tumoral Subtype | |
 Ductal | 76 (90.5) |
 Lobular | 4 (4.8) |
 Mucinous | 3 (3.6) |
 Ducto-Lobular | 1 (1.2) |
Clinical Stage | |
 I | 21 (25.0) |
 II | 49 (58.3) |
 III | 14 (16.7) |
Tumor grade | |
 G1 | 11 (13.1) |
 G2 | 61 (72.6) |
 G3 | 7 (8.3) |
 NR | 5 (6.0) |
Molecular Subtypes | |
 Luminal A | 37 (44.0) |
 Luminal B | 43 (51.2) |
 NR | 4 (4.8) |
Surgery | |
 Breast-conserving surgery | 44 (52.4) |
 Mastectomy | 39 (46.5) |
 No surgery | 1 (1.2) |
Chemotherapy | |
 Adjuvant | 49 (58.3) |
 Neoadjuvant | 25 (29.8) |
 No chemotherapy | 10 (11.9) |
Chemotherapy Regimen | |
 AC + Docetaxel | 36 (42.9) |
 FAC | 21 (25.0) |
 CMF | 18 (21.4) |